Evidence map›Paper›PMID 42352421›Full record

ArticleCancers2026

VITA Accelerator Neutron Sources: Status and Research Results.

Sergey Taskaev, Evgenii Berendeev, Marina Bikchurina, Timofey Bykov, Yulia Chesnokova, Rahaf Deeb, Ibrahim Ibrahim, Anna Kasatova, Dmitrii Kasatov, Yaroslav Kolesnikov and 14 more

Abstract read
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Sergey TaskaevBudker Institute of Nuclear Physics, Novosibirsk 630090, Russia.ORCID 0000-0002-5313-2563
Evgenii BerendeevBudker Institute of Nuclear Physics, Novosibirsk 630090, Russia.ORCID 0000-0002-2747-7162
Marina BikchurinaBudker Institute of Nuclear Physics, Novosibirsk 630090, Russia.ORCID 0000-0003-3561-2990
Timofey BykovBudker Institute of Nuclear Physics, Novosibirsk 630090, Russia.ORCID 0000-0001-6941-9342
Yulia ChesnokovaBudker Institute of Nuclear Physics, Novosibirsk 630090, Russia.
Rahaf DeebBudker Institute of Nuclear Physics, Novosibirsk 630090, Russia.
Ibrahim IbrahimBudker Institute of Nuclear Physics, Novosibirsk 630090, Russia.ORCID 0000-0001-8960-8327
Anna KasatovaBudker Institute of Nuclear Physics, Novosibirsk 630090, Russia.ORCID 0000-0002-6641-9344
Dmitrii KasatovBudker Institute of Nuclear Physics, Novosibirsk 630090, Russia.ORCID 0000-0001-5649-524X
Yaroslav KolesnikovBudker Institute of Nuclear Physics, Novosibirsk 630090, Russia.
Alexey KoshkarevBudker Institute of Nuclear Physics, Novosibirsk 630090, Russia.
Ksenya KuzminaBudker Institute of Nuclear Physics, Novosibirsk 630090, Russia.ORCID 0009-0003-0012-4812
Victoriia MaltsevaBudker Institute of Nuclear Physics, Novosibirsk 630090, Russia.
Georgii OstreinovBudker Institute of Nuclear Physics, Novosibirsk 630090, Russia.
Sergey SavinovBudker Institute of Nuclear Physics, Novosibirsk 630090, Russia.ORCID 0000-0003-2972-5868
Ivan ShchudloBudker Institute of Nuclear Physics, Novosibirsk 630090, Russia.
Stepan ShchukinBudker Institute of Nuclear Physics, Novosibirsk 630090, Russia.
Tatiana SheinBudker Institute of Nuclear Physics, Novosibirsk 630090, Russia.ORCID 0000-0002-7613-9952
Anna ShuklinaBudker Institute of Nuclear Physics, Novosibirsk 630090, Russia.
Nataliia SingatulinaBudker Institute of Nuclear Physics, Novosibirsk 630090, Russia.
Evgeniia SokolovaBudker Institute of Nuclear Physics, Novosibirsk 630090, Russia.ORCID 0000-0002-4493-5612
Igor SorokinBudker Institute of Nuclear Physics, Novosibirsk 630090, Russia.ORCID 0000-0002-2164-3318
Iuliia TaskaevaBudker Institute of Nuclear Physics, Novosibirsk 630090, Russia.ORCID 0000-0002-2812-2574
Gleb VerkhovodBudker Institute of Nuclear Physics, Novosibirsk 630090, Russia.

Funding

Russian Science Foundation 26-12-00020
6 · The paper itself

Abstract

purposeTo develop an accelerator neutron source suitable for boron neutron capture therapy-a new promising method for treating malignant tumors-and to develop dosimetry tools and methods.

methodsResearch into the transport and acceleration of a beam of charged particles, development and manufacture of an accelerator neutron source, study of the radiation generated, and development and implementation of dosimetry tools and methods.

resultsA facility called VITA has been created, which includes a tandem electrostatic accelerator of an original design for producing a 2.3 MeV 10 mA proton beam, a lithium target for generating neutrons in the

conclusionsThe authors strongly recommend using prompt γ-ray spectroscopy in treatment and developing lithium neutron capture therapy, including in combination with BNCT, and note the high efficiency, reliability and compactness of the VITA

Indexed as

beam shaping assemblyboron delivery drugboron neutron capture therapycharged particle acceleratordosimetryneutron producing targetneutron source

Identifiers

PMID42352421
PMCPMC13297151

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.